Bioluminescence images.
- Dominique Abrahams (13106815)
- Arig Ibrahim-Hashim (678045)
- Robert S. Ackerman (17125206)
- Joel S. Brown (7932578)
- Christopher J. Whelan (2910581)
- Megan B. Garfinkel (17125209)
- Robert A. Gatenby (213229)
- Aaron R. Muncey (17125212)
Publication date
October 2023
DOIAbstract
A. In vivo representative bioluminescence ventral view images of mice from the three treatment cohorts; control, isoflurane, and ketamine in C57BL/6 and NSG mice strains. Images are at day 14 post-injection. Bioluminescence signal is more visible in ketamine treated mice in C57BL/6 strain compared to other treatment groups. Bioluminescence signal is equally visible in all treatment groups in the NSG strain. B. Ex vivo representative images of the lung (red arrow), liver (blue arrow), and kidneys (green arrows) from the three treatment cohorts for C57BL/6 and NSG strains. Note the different scale bars in C57BL/6 and NSG.</p
Add to ORKG